Rasna Therapeutics Inc. (2)
- Business Finance (1)
- Uncategorized (1)
- Asset Purchase Agreement between Rasna Therapeutics, Inc. and Tiziana Life Sciences plc dated April 16, 2020 (Filed With SEC on June 29, 2020)
- Form of 12% Convertible Promissory Note (Filed With SEC on February 14, 2019)